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The human metabolome provides a direct physiological read-out of an individual's actual health state
and includes biomarkers that may predict disease or response to a treatment. The discovery and vali-
dation of these metabolomic biomarkers requires large-scale cohort studies, typically involving thou-
sands of samples. This analytical challenge drives novel technological developments to enable faster,
cheaper, and more comprehensive metabolomic analysis: more for less.
This review summarises recent (2012e2018) developments towards this goal in all aspects of the
analytical workflow, in relation to NMR but primarily to mass spectrometry (MS). Recent trends include
miniaturisation and automation of extraction techniques, online coupling to fast analysis methods
including direct infusion ion mobility MS, integrated microfluidic devices, and sharing and standardizing
metabolomics software and data.
The technological advances in metabolomics support its widespread application, integration with
other -omics fields, and ultimately disease prediction and precision medicine.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Metabolomics is defined as an analytical approach for the
identification and quantification of metabolites, i.e. small molecules
with a molecular weight <1500 Da. The Human Metabolome
Database [1] currently contains over 114 000 metabolite entries
such as peptides, lipids, amino acids, nucleic acids, carbohydrates
and organic acids, with a wide dynamic concentration range from
high abundance (>1 mM) to relatively low abundance (<1 nM). The
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read-out of the metabolome provides a wealth of information that
can be used to identify metabolic profiles that predict disease risk,
disease progression, and treatment outcome. Studies have shown
that usually thousands of samples are necessary to find novel
metabolic biomarker profiles, and even more for validation and
replication [2]. The number of samples increases even further when
we want to identify early disease biomarkers using population-
based metabolic profiling. To realise the potential of metab-
olomics for disease prediction and precision medicine, large-scale
data acquisition is needed with sample sizes typically in the or-
der of thousands. The impact and advantages of profiling such large
cohorts, and the effects on study design, were recently elaborately
reviewed by Zampieri et al. [3].
Metabolomics currently uses two main techniques: nuclear
magnetic resonance (NMR) spectroscopy and mass spectrometry
(MS). Mass spectrometry is hereby often coupled with a separation
technique, such as liquid chromatography (LC), gas chromatog-
raphy (GC) or capillary electrophoresis (CE). As recently reported
for the human metabolome database for 2018 (HMDB 4.0) [1], the
number of metabolites with experimentally measured spectra for
NMR, MS/MS, and GC-MS was 1494 (24%), 2265 (36%), and 2544under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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coverage than NMR; the average number of reported metabolites
per analysis is 37 (NMR) and 197 (MS) for human samples in the
MetaboLights and Metabolomics Workbench repositories.1
Nonetheless, NMR is currently more established for high-
throughput analysis than MS in terms of analysis time and cost
per sample. Typically 3e8 min is required for a 1H-NMR profile at
10e25 V/sample versus 5e30 min for an LC-MS profile at 30e150
V/sample, while oftenmore than one LC-MS profile is acquired. The
wider coverage and potential gain in throughput expressed as
metabolites/minute is higher with MS due to its sensitivity, which
explains why more novel technologies are being developed in this
field as compared to NMR.
Concerning sample throughput for MS, direct introduction of a
sample into the ionisation chamber of an MS would yield the
highest throughput. However, a trade-off exists between sample
throughput and metabolite coverage. Introducing mixtures of
compounds of different structures, concentrations, proton affin-
ities, etc. into the ionisation chamber leads to matrix effects;
compounds affect each other's ionisation efficiency. This may
compromise quantification, and in case of ion suppression of low-
abundant analytes it may result in a loss of relevant sample infor-
mation as these analytes are not detected anymore. Additionally, it
is problematic when usingMS only to identify isomeric compounds
with identical fragmentation patterns (e.g. enantiomers or di-
astereoisomers), or to discriminate precursor ions from identical
fragment ions formed by in-source fragmentation (e.g. adenosine
triphosphate fragmenting in-source into adenosine diphosphate).
The key to minimizing these effects is to use sample preparation
and/or sample separation prior to MS. However, these steps usually
increase both analysis time and costs.
The analytical challenge posed by high-throughput metab-
olomics drives technological developments into the direction of
more exhaustive analysis using smaller samples and shorter anal-
ysis times at a lower cost-per-sample: more for less. This review
intends to identify recent developments and trends for metab-
olomics from 2012 onwards, that are promising for higher sample
throughput without compromising metabolite coverage or vice
versa. We will start with a short literature overview on the 6-year
trends of the more established metabolomics techniques. After a
brief discussion on recent NMR developments, we will discuss
promising developments spanning the entire mass spectrometry-
based workflow, from sample preparation, separation, and intro-
duction for MS, to data acquisition and data analysis.
2. Discussion
2.1. Literature overview
A literature survey of publications on metabolomics in the
period 2012e2018 (Fig. 1A) shows the growing importance and
adaptation of metabolomics, continuing a trend that was previ-
ously observed by Kuehnbaum and Britz-McKibbin [4]. The pro-
jected number of publications for 2018 where the analytical
technique is specified is expected to reach approximately 2200. The
trends in Fig. 1B show that LC-MS has recently overtaken NMR as
the dominant technique reported in peer-reviewed publications,
while CE-MS remains a rather niche technique. Furthermore, Fig.1C
shows the growing use of fast sample introduction techniques for
MS (e.g. direct injection and ambient desorption) and ion-mobility
separations.1 Data extracted on October 31st, 2018. Studies with no metabolites reported
were excluded.2.2. NMR
One-third of the recent academic publications in metabolomics
report NMR as the used technique (Fig. 1B). NMR is highly repro-
ducible, suitable for high-throughput analysis, cost-efficient, and
still unrivalled when it comes to quantitation, or structural iden-
tification of unknown compounds. Compared to GC-MS and LC-MS,
NMR offers complimentary information for the analysis of more-
abundant metabolites that are difficult to ionise or would require
derivatisation, or are at very high concentrations. Its main down-
side is that it lacks sensitivity compared to MS.
The future of NMR-based metabolomics has been reviewed by
Markley et al. [5]. Strategies to improve NMR sensitivity include
established techniques such as the introduction of higher field
magnets (operating at frequencies of 1.2 GHz or higher) [6] and
cryogenically-cooled NMR probes [7], and emerging techniques
such as high-temperature superconducting coils [8], microcoil-
NMR probes [9], and hyperpolarization. As the costs for higher
field (>600 MHz) NMR systems and cryo-probes are significant,
microcoil NMR presents a cost-efficient approach to increase
sensitivity especially for biomass-limited samples. Currently, with
600 MHz NMR systems using 150 mL NMR probes, metabolites can
be detected in the low nanomole-range with sufficient resolution
for the detection of 50e100 metabolites, whereas with a 30 mL
cryoprobe sub-nanomole amounts can be detected. Recently, 1 mL
and sub-mL microcoil NMR probe heads have been developed,
which are able to detect compounds down to 25 pmol with a
400 MHz NMR system [10]. Alternatively, hyperpolarization may
offer a cost-efficient approach to improve NMR sensitivity. A
recently developed method, SABRE-SHEATH, overcomes the short
spin lifetimes (typically seconds) of biologically-relevant molecules
by direct hyperpolarization of 15N2 magnetization at room tem-
perature and longer-lived 15N2 singlet spin order. Theis et al. re-
ported over 10 000-fold enhancements generating detectable NMR
signals for over an hour [11]. A current limitation is that molecular
tags, e.g. diazirines, are selective for certain classes only. A different
recent trend is the use of compact low-field NMR instruments
which use permanent magnets in the range of 1e2 T, as reviewed
by Blümich et al. [12] These compact and low-cost systems lower
the threshold for the use of NMR in a range of applications
including real-time reaction monitoring and quality control at an
industrial site or research laboratory, albeit at the expense of
sensitivity, and the need for proper sample preparation.2.3. Sample preparation prior to MS
Mass-spectrometric analysis of complex samples poses a chal-
lenge due to matrix-related background noise and ion suppression,
especially in the case of direct sample introduction. In case of
untargeted metabolomics, sample preparation should be generic;
therefore dilution or simple protein precipitation is often applied.
On the other hand, when doing targeted metabolomics, selective
extractions and stabilisation of metabolites can bemore favourable.
These extraction methods, including solid-phase extraction (SPE)
and liquid-liquid extraction (LLE) can provide enrichment of the
analytes from the matrix in a fraction of the time and costs of
sample separationmethods such as LC. Although thesemethods are
robust, their preconcentration capacity is often limited, especially
for complex or biomass-limited samples. Furthermore, their
selectivity is often mentioned as a risk for bias, however it can be
utilised to fractionate metabolite classes for subsequent analysis,
for example shotgun lipidomics [13]. Recent trends in sample
preparation include miniaturisation to improve preconcentration
factors and extraction time while reducing reagent consumption
Fig. 1. Literature survey of publications with metabolom* OR metabonom* in the title, abstract, or keywords in the period 2012e2018y (up to May 7th, 2018) on Web of Science: (A)
number of publications mentioning the use of the main techniques in metabolomics: NMR, LC-MS, GC-MS and CE-MS, or multiple; (B) relative number of publications (trend plot) of
the main techniques in metabolomics; (C) number of mass spectrometry-related publications mentioning the use of fast sample introduction methods (direct injection and ambient
desorption ionisation), ion-mobility separation, or a combination of these. Further details can be found in the Supplementary Information.
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driven extractions.
2.3.1. Solid-phase extractions
Hyphenation of SPE and MS has potential for high-throughput
analysis with deeper metabolite coverage. A wide variety of
different solid phases is available (e.g. hydrophobic, mixed-mode,
charged surfaces) which allow the enrichment of various metabo-
lite classes. However, conventional packed-bed SPE cartridges often
have limited preconcentration power due to their poor separation
efficiency and the cumbersome elution step. The sample volume,
biomass loaded and complexity dictate the required bed capacity e
and therewith the minimal elution volume e which limits the
preconcentration factor.
Zhang et al. achieved sample-to-sample cycle times of 15 s with
an automated SPE-IMS-MS setup based on a commercially-
available automated SPE device (RapidFire, Agilent), using several
small-volume SPE cartridges (mixed mode, graphitic carbon, and
HILIC) [13]. This automated SPE systems results in a significant gain
in throughput. However, the packed-bed cartridges still require
relatively large elution volumes which limits the upconcentration
for low-abundant metabolites.
Solid-phase microextraction (SPME) has been introduced to
address some of these challenges. A polymer-coated fibre with a
variety of available surface functionalities can be inserted directly
into the vial headspace, into the liquid sample, or can even be
exposed in vivo. The fibre is then transferred to an analytical
platform for desorption and analysis. Direct coupling of SPME to
MS remains challenging [15], and a promising development has
addressed this via an Open Port Probe (OPP) interface [16]. One of
the advantages of eluting directly into the probe is that dilution is
minimised. While this workflow still includes time-consuming
steps such as equilibration of the fibre (30 min) and sample-
extraction (up to 5 min), it has potential for high throughput
(less than 20 s per sample) since these steps can be automated and
performed in parallel. SPME for metabolomics is fairly new and its
major drawback is relatively low metabolite coverage. It has
proven its value in small-scale studies with various biofluids, and
with the ongoing development of sorbent material we expect its
application in larger studies with broader metabolite coverage to
follow soon [17].
2.3.2. Liquid-liquid micro extraction (LLME)
LLE enables the fractionation of hydrophilic and hydrophobic
metabolites in two immiscible phases (i.e. aqueous and organic). Assamples for metabolomics are mostly aqueous (e.g. body fluids),
LLE is used for either removal or extraction of hydrophobic me-
tabolites (e.g. Bligh & Dyer). Theoretically, high preconcentration
factors can be achieved by extracting into a small volume, but for
practical reasons often relatively large volumes are still used. De-
velopments in liquid-liquid micro extraction (LLME), whereby
samples are extracted in microliter-range volumes of extraction
solvent, have overcome these practical issues and have significantly
improved extraction kinetics and preconcentration factors.
LLME approaches can be categorized as dispersive and non-
dispersive (DLLME and nDLLME, respectively). In DLLME, a liquid
is used to disperse the small-volume extraction solvent in order to
drastically increase the effective surface area, resulting in near-
instantaneous extraction [18]. DLLME methods still require a
phase-separation step which proves to be challenging to automate
for high-throughput analysis [19]. In nDLLME, analytes are extrac-
ted into a small-volume acceptor phase, e.g. a droplet. Droplet-
based or continuous-flow approaches have been realised on
microfluidic chips, which could lead to automated and parallelised
extraction. On-line droplet-based three-phase LLME was demon-
strated with almost 3 orders of magnitude upconcentration in
several minutes [20]. While the extraction kinetics of nDLLME are
slightly slower compared to DLLME, this is compensated by its
greater potential for automation [21].2.3.3. Emerging preconcentration technologies
Electro-driven extractions (EE) target the polar, charged analy-
tes which constitute a large part of the human metabolome.
Although EE has been around for many years, its use is not as
widespread as SPE and LLE. It is exclusively applicable to chargeable
metabolites and as it is based on electro-migration it has mostly
been associated with CE. Recent developments increase the
versatility of EE for hyphenation to LC, GC or direct injection [22].
EE offers tuneable selectivity and shows potential for increased
throughput and high preconcentration factors. By using a small-
volume acceptor phase, EE can offer simultaneous enrichment
and preconcentration. This has been demonstrated with two-phase
[23] or three-phase [24] on-chip EE, whereby in the latter case the
intermediate organic layer acts as a filter for hydrophobic metab-
olites. Automated three-phase EE into a 2-mL droplet directly
coupled to nanoESI-MS has been used for metabolomics to extract
acylcarnitines in 3 min, as shown in Fig. 2A [25]. Similarly, electro-
membrane extraction (EME) utilises a membrane impregnated
with organic solvent as a filter. Recent developments to perform
Fig. 2. Two examples of electro-driven sample preparation. A) Three-phase droplet
electroextractions. Video stills of crystal violet subjected to three-phase EE at t ¼ 0 and
t ¼ 3 min after applying the voltage. Reprinted with permission from Ref. [25].
Copyright 2013 American Chemical Society. B) Schematic overview of a parallel-
electromembrane extraction (Pa-EME) device using filtration 96 well-plate. Reprin-
ted with permission from Ref. [26]. Copyright 2017 American Chemical Society.
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significant step towards large-scale automation [26].
Alternatively, preconcentration techniques can be used to
further improve sensitivity for low-abundant analytes, comple-
mentary to prior enrichment steps. Two developments for
controlled solvent reduction feature vacuum-assisted membrane
evaporation [27] andmachine-vision controlled evaporation from a
pendant droplet [28]. The former achieved a 10-fold solvent
reduction in 60 min, whereas the latter achieved 10-fold reduction
in a few minutes without significant loss of volatiles.Fig. 3. Perfectly-ordered micropillar-array LC column for increased separation effi-
ciency. A) Schematic overview of the different zones of a microfluidic device con-
taining pillar-array columns. 1: inlet mobile phase, 2: inlet sample phase, 3: outlet
sample phase, 4: injection box, 5: inlet distributor, 6: channel track, 7: connecting turn,
8: mobile phase outlet. B) Optical fluorescence microscope image of the box at the
channel section in A. Reproduced from Ref. [33] with permission of The Royal Society
of Chemistry.2.4. Sample separation prior to MS
2.4.1. LC-MS
Compared to GC and CE, LC is the most popular separation
strategy to hyphenate with MS in metabolomics research (Fig. 1A).
The development of novel LC technologies aiming to increase both
sample throughput and metabolite coverage has accelerated since
the introduction of the first commercially-available ultra-high
pressure liquid chromatography (UHPLC) systems in 2004, allowing
high operating pressures (now up to 1400 bar) and flow rates (now
up to 5 mL/min). A number of excellent reviews have recently been
written on this topic [29,30].
Several ongoing trends can be distinguished, in the first place
towards use of smaller (sub-2 mm) particle-size packed columns.
These lead to higher separation efficiency due to a reduction in
eddy diffusion and decreased resistance to mass transfer and
shorter analysis times due to higher optimal flow velocity. While
reversed-phase (RP) separation remains the most popular tech-
nique, complementary separation mechanisms such as hydrophilic
interaction chromatography (HILIC), ion-exchange, and chiral LC
are also becoming available in sub-2 mm particle size formats [31].
Secondly, a trend towards decreasingmobile-phase viscosity can be
observed, including strategies such as the use of elevated mobile-phase temperature (>60C), separation modes based on mobile
phases with a high organic content (e.g. HILIC) or a low-viscosity
(co-)solvent (e.g. CO2 for supercritical fluid chromatography, SFC)
[32]. With respect to the pressure limits of the LC system, lowering
the viscosity of themobile phase allows to achieve higher flow rates
resulting to shorter analysis times. Additionally, the increase in
solute diffusivity at higher temperatures leads to a higher optimal
flow velocity and enhanced mass transfer kinetics. A third trend is
the optimisation of column technology, including the use of core-
shell particles which offer an increased efficiency due to reduc-
tion of eddy diffusion, longitudinal diffusion, and an improvement
in mass-transfer resistance, even at high linear flow rates. Likewise,
the use of perfectly-ordered pillar-array columns [33] as shown in
Fig. 3 or silica-based monolithic columns with higher permeability
[34] has been typically explored for high-efficiency separation of
complex samples. However, it can also be used to gain separation
power in gradient separations of only several minutes [35].
While a plethora of chromatographic columns and conditions is
available, finding the right combination for an application can be a
daunting task. Kinetic plots as introduced by Desmet and co-
workers are a powerful tool to compare the performance of chro-
matographic systems [36]. These plots take into account informa-
tion about the interplay between pressure, mobile-phase velocity
and plate height, and their effects on the performance of different
columns, in order to find the best possible combination of particle
size, column length and temperature. If higher separation effi-
ciencies and deeper metabolite coverage are necessary, multi-
dimensional separations such as online comprehensive two-
dimensional liquid chromatography (LCLC) can be used. Its two
main advantages are greater selectivity by the use of two
P. Miggiels et al. / Trends in Analytical Chemistry 120 (2019) 115323 5independent (orthogonal) retention mechanisms targeting
different sample dimensions, and higher resolving power as the
total peak capacity can be approximated by the product of the in-
dividual peak capacities. However, using LCLC to its full potential
can be difficult as design challenges include selecting orthogonal
separation mechanisms, and solving eluent-compatibility issues
between the two dimensions [37]. We expect that the use of pre-
dictive software-tools and optimisation algorithms to establish
optimal conditions [38] will increase the use of LCLC in metab-
olomics in the coming years.
2.4.2. CE-MS
Capillary electrophoresis is predominantly hyphenated to mass
spectrometry via ESI with a sheath-liquid interface. However,
interfacing CE and ESI-MSwith sufficient sensitivity and robustness
has proven to be challenging. Current developments in bioanalysis
applications mostly focus on increasing sensitivity, as was recently
reviewed by Ramautar et al. [39]. Sheathless ESI-MS interfacingwas
introduced to reduce sample dilution and background noise,
resulting in more information per sample and pM-range levels of
detection. Other approaches successfully reduced the sheath-liquid
flow to tackle sheathless interfacing issues, with minimal loss in
sensitivity [40]. Sheath-liquid CE-MS is still advantageous for sta-
bility, and platinum (alloy) emitter tips are currently being adapted
to overcome corrosion issues and further boost robustness for
large-scale application. On-line coupling of SPE-CE-MS further aids
to remove matrix compounds and improve the limits of detection
[39]. Additionally, the isocratic nature of CE separations allows for
multi-segment or overlapped injections, wherebymultiple samples
are injected in a single run and separated simultaneously to
improve throughput [41]. The samples can be uniquely identified
afterwards based on their mass spectra. Finally, CE allows for
unique electrophoretic sample preconcentration methods gener-
ally referred to as “stacking”. A recent review showed that de-
velopments in stacking methods have led to sensitivity gains of
several orders of magnitude [42]. CE has superior separation power
and speed compared to LC-MS, and advances in MS-interfacing
have brought sensitivity up to par. However, stability issues still
prevent large-scale adaptation.
2.4.3. Ion-mobility separations
With the increasing number of commercially-available systems
enabling ion-mobility separation (IMS), this gas-phase electro-
phoretic technique is an upcoming trend in metabolomics. It sep-
arates ions based on their shape, size, and charge. The measured
drift time can be converted into the collisional cross section (CSS), a
unique physicochemical property of an ion. A review by Ewing et al.
[43] comprehensively describes the various technologies within
ion-mobility separation, which are either dispersive (keeping all
ions for MS analysis) or selective (excluding ions based on
mobility). For metabolomics, the dispersive techniques drift-tube
ion mobility (DTIMS) and travelling-wave ion mobility (TWIMS)
have most commonly been applied over the last decade, but
recently also selective techniques such as differential mobility
separation (DMS) are gaining in popularity [44]. While dispersive
techniques are inherentlymore suitable for untargeted analysis, the
selective techniques provide better orthogonality to mass spec-
trometric data. Recent developments in ion mobility aimed to in-
crease the separation resolution and reduce the loss of ions. An
example is prolonging the drift tube (and with that the resolution)
using Structures for Lossless Manipulations (SLIM). When used in a
smart arrangement, e.g. serpentine, which could even be combined
with ion escalators and elevators to createmulti-level SLIM devices,
the length of the ion path can be increased without the need to
increase the travelling-wave voltage with tube length [45,46].Another interesting approach increasing the separation resolution
was introduced with Trapped Ion Mobility Spectrometry whereby
ions are hold stationary against a moving gas instead of the other
way around [47].
Adding ion-mobility separation to LC-MS or SPE-MS analysis is
appealing as the separation occurs in the milliseconds time scale, is
orthogonal to e.g. LC and SPE, and is (low-) orthogonal to MS. As
such, it can increase the peak capacity of regular LC separations and
provide an extra identifier for metabolite identification [48,49].
Additionally, ion mobility has the potential to separate isomers
based on their shape and has even been applied to separate chiral
components [50]. Ion-mobility separation has been used for
metabolomics studies, albeit limited in sample size. Examples
include its application for the characterization of metabolic
changes in colorectal cancer by Williams et al. and for the com-
parison of the metabolome of different cells involved in cancer
development by Paglia et al. [51,52]. For more widespread use in
the metabolomics field, ion mobility has a few limitations still to
overcome. It can for example reduce sensitivity and increases file-
sizes. For example, the ion-mobility MS method of Williams et al.
needed 1.5 min in addition to each 3.5 min of data acquisition per
sample to allow the large data files to be saved. In addition, if used
in combination with LC ion mobility complicates data analysis by
the additional dimension it provides. As it requires a longer scan
time, the number of data points per peak (and consequently the
peak capacity in ultrafast chromatographic separations) is limited
and the separationwill not aid the quantitative analysis as it occurs
after the ionisation.
2.5. Sample introduction for MS
2.5.1. Direct sample introduction
For direct sample introduction, we can distinguish between
direct infusion (DI) and flow-injection analysis (FIA). In DI-MS, a
sample is continuously introduced into the ionisation chamber
with a pump. While DI maintains the sample concentration, it
suffers from large sample consumption and the need for extensive
rinsing in between samples. For FIA, a sample plug is injected into a
continuous fluid stream towards the MS. While consuming less
sample and allowing drastically increased throughput, FIA does
face a trade-off in sensitivity between dilution and ion suppression.
Ion suppression can be reduced by mild dilution to gain sensitivity,
however too much dilution will again result in loss of sensitivity.
Additionally, any hypothesis has to be confirmed with subsequent
targeted MS analysis if the signal cannot be uniquely identified due
to limited separation or in-source fragmentation.
The biggest challenge related to direct sample introduction re-
mains ion suppression, and as a result the relatively low number of
metabolites that can be detected and quantified. As an alternative
to direct sample introduction, a sample can be introduced by
various forms of ambient desorption directly from sample surfaces,
categorised as i) spray- or jet-based ambient ionisation techniques
(e.g. DESI, desorption electrospray ionisation), ii) electric discharge-
based ambient ionisation techniques (e.g. DART, direct analysis in
real time), iii) ambient gas-, heat- or laser-assisted desorption/
ionisation techniques (e.g. EESI (electrospray-assisted laser
desorption/ionisation), and iv) acoustic or ultrasonic waves (e.g.
surface acoustic wave nebulisation (SAWN) and acoustic droplet
ejection (ADE)) [53]. In this latter category, the ADE-MS interface
(Fig. 4A) acoustically eject (sub)nL sample droplets from a micro-
titer plate directly to the MS at a rate of up to 3 samples per second
for high-throughput analysis of small samples [54]. Ambient MS
techniques have recently been reviewed by Clendinen et al. with
respect to their (increasingly popular) use in metabolomics [55].
They reported the advantages and limitations of eight ambient MS
Fig. 4. Two novel developments to increase throughput in sample introduction and separation. A) Schematic overview of ADE-MS high-throughput interface, whereby (sub)nL
droplets of sample are acoustically ejected into the mass spectrometer through a transfer tube. Combined, these droplets form an equivalent flow of low mL/min-range. Reprinted
from Ref. [54] with permission by SAGE Publications, Inc. B) Chromatogram of temperature-gradient chip-HPLC shows more than twofold decrease in separation time. Reprinted
with permission from Ref. [59]. Copyright 2017 American Chemical Society.
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metabolomics. In general, the advantages of ambient MS are the
reduced need for sample preparation, suitability for high-
throughput analysis (seconds per sample), high sensitivity (sub-
ng detection limits), and the quantitative capabilities (accuracy and
precision) provided that proper internal standards are used. Dis-
advantages include its sensitivity tomatrix effects, emphasising the
need to use standards for reliable quantification. Ambient desorp-
tion directly from sample surfaces is still an emerging technique
and has not yet been used for large cohort metabolic profiling. A
promising ambient mass-spectrometric imaging development was
recently reported by Abliz and co-workers [56], describing the use
of air flow-assisted desorption electrospray ionization (AFADESI)
for a sensitive and spatial in-situ analysis of tumormetabolism from
lung cancer tissue samples and multivariate statistical analysis
(MVSA) for identification of diagnostic biomarkers. This develop-
ment could enable imaging analysis to be used as a molecular
pathological tool for rapid, label-free histopathological diagnosis
and image-guided surgery.
2.5.2. Hyphenation of microfluidic devices with MS
Integrated microfluidic devices for sample preparation, separa-
tion and/or introduction are emerging in the field of bioanalysis.
Miniaturisation allows the incorporation of different components,
e.g. the stationary phase and an ESI-tip, into a microfluidic platform
with low dead-volume connections to minimise band-broadening
effects [57]. Furthermore, downscaling the system offers advan-
tages such as improved sensitivity with concentration-dependent
detectors, and increased ionisation efficiency of electrospray-
ionisation mass spectrometry (ESI-MS) due to the low flow rates
[58]. Examples of commercially-released devices include the Ion-
Key (Waters) and HPLC-Chip (Agilent) chipLC-ESI devices, and the
ZipChip (908 Devices) chipCE-ESI device. A recent temperature-
gradient chip-HPLC approach demonstrates the advantage of low
thermal mass of chips for rapid and extreme temperature cycling.
This system reduced the separation time by a factor of 2 down to
20 s for six analytes (Fig. 4B) [59].
Alternatively, digital microfluidics platforms allow for fast and
accurate manipulation of small volumes of sample and reagent,
such as addition of internal standards, and can be directlyinterfaced to MS with an on-chip emitter tip [60]. Moreover,
droplet or digital microfluidics shares its discrete and array-based
traits with desorption/ionisation techniques, making it an attrac-
tive match for desorption-basedMS such as nanostructure-initiator
mass spectrometry (NIMS) as an advanced, high-throughput
technique [61]. Electro-driven separations also benefit greatly
from the short distance between separation and detection with
microfluidic chips, as it eliminates the need for long capillaries that
inherently increase separation times. This was for example
demonstrated for the analysis of pharmaceuticals [62] and amino
acids [63] in under 3 min.
Considering these developments, and the availability of com-
mercial solutions, it is clear that integrated microfluidics tools are
promising for bioanalysis of low-volume samples. In the coming
years, it could prove itself for large-scale, exhaustive, high-
throughput metabolomics.2.6. MS data acquisition
The trend to achieve more for less in mass spectrometry-based
metabolomics is reflected by the increasing use of high-resolution
mass spectrometry (HRMS) for combined targeted and untar-
geted analysis and for simultaneous quantitative and qualitative
analysis. Accordingly, development of MS data-acquisition pro-
tocols relates to this by offering possibilities for data-dependent
and data-independent acquisition (DDA and DIA), whereby apart
from a TOF-MS scan also MS/MS scans are being collected to obtain
more information about the molecular structure [64]. In DDA, an
MS/MS event can be triggered based on intensity, isotope pattern,
or mass defect. Although the quality of the produced spectra is
generally good, its drawbacks include missing interesting targets
due to the stochastic nature of chosen selection criteria, and
increasing the duty cycle time, thereby decreasing the number of
data points per peak and affecting quantitative analysis. As a result,
DIA techniques are more attractive for untargeted metabolomics.
Within these data-independent protocols, a distinction can be
made between those fragmenting all ions at once (e.g. all ion
fragmentation (AIF), MSE) and those consecutively fragmenting
selected precursor ion windows (sequential window acquisition of
P. Miggiels et al. / Trends in Analytical Chemistry 120 (2019) 115323 7all theoretical fragment ion spectra, SWATH). The latter generally
produce cleaner MS/MS spectra, but at a cost of the duty cycle time.
2.7. Data (pre-)processing, analysis and exchange
Finally, the acquired metabolomics data needs to be translated
to useful biological insights, a process that includes data pre-
processing, peak annotation, post-processing, statistical analysis
and pathway analysis. The increased data-acquisition rates, data
complexity and study size bring new challenges for the process of
data processing, analysis and exchange, similar to other fields that
face increasing data quantities, such as high-throughput
microscopy.
Metabolomics data comes in a wide variety, from NMR spectra
to direct-injection MS or multidimensional separation-MS data.
One challenge is the incompatibility of data formats between
different processes or different software versions. Besides data
processing and analysis with (non-complimentary) vendor soft-
ware, we see an increasing availability of open-source and free-to-
use software tools (comprehensively reviewed by Spicer et al. [65])
which can perform one or more of these tasks. The BioContainer
and the PhenoMeNal consortium address incompatibility by crea-
tion and online deposition of software containers that remove in-
compatibilities caused by dependencies of the installation or the
version [65]. Additionally, these containers can reproduce data
analysis with the exact same software conditions.
A related second challenge is to make research data Findable,
Accessible, Interoperable and Reusable (FAIR) so that data of
different studies can be combined [66]. An important tool to realise
FAIR metabolomics data is the introduction and increasing use of
metabolomics data repositories, such as the MetaboLights database
(Europe) [67] andMetabolomicsWorkbench (United States) [68]. To
facilitate their use by the international community, efforts are being
made to allow easy sharing and exchanging of data between re-
positories as exemplified by the creation of the online resource
MetabolomeXchange (http://www.metabolomexchange.org),
which lists the available (meta-)data sets from the various re-
positories. An additional advantage of these repositories is that it
stimulates the metabolomics community towards the highly
necessary data reporting standards [69]. Standardisation allows to
combine multiple datasets within the field of metabolomics to in-
crease statistical power, but also to integrate data with the other
eomics fields formore exhaustive analysis of biological phenomena.
A third challenge is the computational power required to anal-
yse the data sets and files with extraordinarily high information
density. To illustrate this, May and McLean calculated theoretically
that peak capacities exceeding 1012 could be achieved when
coupling three-dimensional MS imaging with ion mobility and
TOF-MS, with a peak-production rate of around 106 s1 [70]. To
address this challenge, the metabolomics society is increasingly
making use of cloud-computing technologies, such as XC-MS On-
line and OpenMSI, wherein data-intensive computational work is
distributed across a network of computers [70]. A downside of this
solution is the additional time required for data uploading and
downloading.
With all these challenges it is easy to overlook the primary,
seemingly trivial challenge: peak integration. This pivotal process
in metabolic data analysis often still requires laborious manual
checks to ensure that no noise has been misinterpreted as a peak
and that peaks have been correctly integrated for quantitation. We
envision that with increased availability of metabolomics data, al-
gorithms can be better trained to this end and can benefit from self-
learning tools. The alternative is to rely on vast amounts of data,
whereby the power of using large numbers compensates errors
caused by noise.3. Conclusion
Metabolomics is a rapidly expanding field, yet its broad imple-
mentation is still hampered by low sample throughput and high
cost per analysis. In this review, we have discussed recent tech-
nological developments and trends for metabolomics towards
faster and more exhaustive analysis using smaller samples at a
lower cost-per-sample:more for less. For the workhorse techniques,
NMR and LC-MS, the developments mostly focus on gaining
sensitivity (e.g. microcoil NMR and hyperpolarization) and faster/
more efficient separations (e.g. UHPLC, reduced viscosity, improved
column technologies). Developments in sample preparation are
focused on miniaturisation, increased efficiency, and automation
for online coupling to MS. Hyphenation of sample separation with
MS still provides deeper metabolite coverage compared to direct
injectionMS, and through the emergence of microfluidic chips with
an integrated separation column and electrospray emitter, speed
and costs can be drastically improved. Likewise, we observe an
increased use of ion mobility for ultra-fast separations. Combined
with fast sample preparation, this may lead to increased metabolite
coverage in a relatively short analysis time. The increasing possi-
bilities of data sharing initiatives, together with standardised data
reporting, aid the development of fully-automated (open-source)
data analysis platforms required to process the vast amounts of
data acquired, and to integrate this data with other omics fields to
enable novel biological insights.
We are convinced that by recent developments for all steps in
the analytical workflow, metabolomics is on a fast lane towards
wider implementation, comparable to the rise of genomics.
Widespread integration of the omics fields may then pave the way
to disease prediction and precision medicine, using metabolomics
data obtained far more cost-efficiently than today.
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